CSH2 | Chorionic somatomammotropin hormone 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
KISS1 | KiSS-1 metastasis-suppressor | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
CSHL1 | Chorionic somatomammotropin hormone-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CSH1 | Chorionic somatomammotropin hormone 1 (placental lactogen) | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
GH2 | Growth hormone 2 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
CGB8 | Chorionic gonadotropin, beta polypeptide 8 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB5 | Chorionic gonadotropin, beta polypeptide 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PSG11 | Pregnancy specific beta-1-glycoprotein 11 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB | Chorionic gonadotropin, beta polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ISM2 | Isthmin 2 | Predicted secreted proteins
| | | | | Tissue enriched |
XAGE2B | X antigen family, member 2B | Predicted intracellular proteins
| | | | | Tissue enriched |
PLAC1 | Placenta-specific 1 | Predicted secreted proteins
| | | | | Tissue enriched |
HSD17B1 | Hydroxysteroid (17-beta) dehydrogenase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
CGB1 | Chorionic gonadotropin, beta polypeptide 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
GH1 | Growth hormone 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
TFPI2 | Tissue factor pathway inhibitor 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALPP | Alkaline phosphatase, placental | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SIGLEC6 | Sialic acid binding Ig-like lectin 6 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GCM1 | Glial cells missing homolog 1 (Drosophila) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
PAPPA | Pregnancy-associated plasma protein A, pappalysin 1 | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGA | Glycoprotein hormones, alpha polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB2 | Chorionic gonadotropin, beta polypeptide 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
HSD3B1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
TAC3 | Tachykinin 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CHAT | Choline O-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
PRG2 | Proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
LIN28B | Lin-28 homolog B (C. elegans) | Predicted intracellular proteins
| | | | | Tissue enriched |
PAPPA2 | Pappalysin 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FBN2 | Fibrillin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
IGF2 | Insulin-like growth factor 2 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
MAGEA8 | Melanoma antigen family A, 8 | Predicted intracellular proteins
| | | | | Tissue enriched |
VGLL1 | Vestigial-like family member 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
MSMP | Microseminoprotein, prostate associated | Predicted intracellular proteins
| | | | | Tissue enriched |
EBI3 | Epstein-Barr virus induced 3 | Predicted secreted proteins
| | | | | Tissue enriched |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
PAGE4 | P antigen family, member 4 (prostate associated) | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |